share_log

Reshape Lifesciences FY23 Sales $8.678M Miss $8.904M Estimate

Reshape Lifesciences FY23 Sales $8.678M Miss $8.904M Estimate

Reshape Lifesciences 23財年銷售額爲867.8萬美元，未達到預期的890.4萬美元
Benzinga ·  04/02 04:08

Reshape Lifesciences (NASDAQ:RSLS) reported quarterly sales of $8.678 million which missed the analyst consensus estimate of $8.904 million by 2.54 percent.

Reshape Lifesciences（納斯達克股票代碼：RSLS）公佈的季度銷售額爲867.8萬美元，比分析師共識估計的890.4萬美元低2.54％。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論